BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1111 related articles for article (PubMed ID: 16251184)

  • 1. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT.
    Almeida M; Han L; Bellido T; Manolagas SC; Kousteni S
    J Biol Chem; 2005 Dec; 280(50):41342-51. PubMed ID: 16251184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-cadherin negatively regulates osteoblast proliferation and survival by antagonizing Wnt, ERK and PI3K/Akt signalling.
    Haÿ E; Nouraud A; Marie PJ
    PLoS One; 2009 Dec; 4(12):e8284. PubMed ID: 20011526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role of nuclear factor of activated T cells (NFAT)-mediated Wnt signaling in osteoblast differentiation induced by strontium ranelate.
    Fromigué O; Haÿ E; Barbara A; Marie PJ
    J Biol Chem; 2010 Aug; 285(33):25251-8. PubMed ID: 20554534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
    Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
    J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMP9 directly induces rapid GSK3-β phosphorylation in a Wnt-independent manner through class I PI3K-Akt axis in osteoblasts.
    Eiraku N; Chiba N; Nakamura T; Amir MS; Seong CH; Ohnishi T; Kusuyama J; Noguchi K; Matsuguchi T
    FASEB J; 2019 Nov; 33(11):12124-12134. PubMed ID: 31365832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural Cell Adhesion Molecule Regulates Osteoblastic Differentiation Through Wnt/β-Catenin and PI3K-Akt Signaling Pathways in MC3T3-E1 Cells.
    Cheng BF; Feng X; Gao YX; Jian SQ; Liu SR; Wang M; Xie YF; Wang L; Feng ZW; Yang HJ
    Front Endocrinol (Lausanne); 2021; 12():657953. PubMed ID: 34054729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Wnt3a-mediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells.
    Oloumi A; Syam S; Dedhar S
    Oncogene; 2006 Dec; 25(59):7747-57. PubMed ID: 16799642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin promotes osteoblastic differentiation through the BMP/ERK/Wnt signaling pathways.
    Park KH; Kang JW; Lee EM; Kim JS; Rhee YH; Kim M; Jeong SJ; Park YG; Kim SH
    J Pineal Res; 2011 Sep; 51(2):187-94. PubMed ID: 21470302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PI3K/AKT pathway promotes fracture healing through its crosstalk with Wnt/β-catenin.
    Dong J; Xu X; Zhang Q; Yuan Z; Tan B
    Exp Cell Res; 2020 Sep; 394(1):112137. PubMed ID: 32534061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connexin43 enhances Wnt and PGE2-dependent activation of β-catenin in osteoblasts.
    Gupta A; Chatree S; Buo AM; Moorer MC; Stains JP
    Pflugers Arch; 2019 Sep; 471(9):1235-1243. PubMed ID: 31240382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase.
    Liu Y; Rubin B; Bodine PV; Billiard J
    J Cell Biochem; 2008 Oct; 105(2):497-502. PubMed ID: 18615587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt5a and Wnt11 inhibit the canonical Wnt pathway and promote cardiac progenitor development via the Caspase-dependent degradation of AKT.
    Bisson JA; Mills B; Paul Helt JC; Zwaka TP; Cohen ED
    Dev Biol; 2015 Feb; 398(1):80-96. PubMed ID: 25482987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of matrix metalloproteinase-13 and tissue inhibitor of matrix metalloproteinase-1 gene expression by WNT3A and bone morphogenetic protein-2 in osteoblastic differentiation.
    Nakashima A; Tamura M
    Front Biosci; 2006 May; 11():1667-78. PubMed ID: 16368545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors.
    Sinha D; Wang Z; Ruchalski KL; Levine JS; Krishnan S; Lieberthal W; Schwartz JH; Borkan SC
    Am J Physiol Renal Physiol; 2005 Apr; 288(4):F703-13. PubMed ID: 15572521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wingless (Wnt)-3A induces trophoblast migration and matrix metalloproteinase-2 secretion through canonical Wnt signaling and protein kinase B/AKT activation.
    Sonderegger S; Haslinger P; Sabri A; Leisser C; Otten JV; Fiala C; Knöfler M
    Endocrinology; 2010 Jan; 151(1):211-20. PubMed ID: 19887570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation.
    Haÿ E; Laplantine E; Geoffroy V; Frain M; Kohler T; Müller R; Marie PJ
    Mol Cell Biol; 2009 Feb; 29(4):953-64. PubMed ID: 19075000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts.
    Nakashima A; Katagiri T; Tamura M
    J Biol Chem; 2005 Nov; 280(45):37660-8. PubMed ID: 16150699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms.
    Dai J; Hall CL; Escara-Wilke J; Mizokami A; Keller JM; Keller ET
    Cancer Res; 2008 Jul; 68(14):5785-94. PubMed ID: 18632632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of ErbB3 by Wnt3a contributes to wnt-induced osteoblast differentiation in mesenchymal cells.
    Jullien N; Maudinet A; Leloutre B; Ringe J; Häupl T; Marie PJ
    J Cell Biochem; 2012 Jun; 113(6):2047-56. PubMed ID: 22274864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
    Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
    Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.